2.2. Microarray
MAMMARY TUMOR
For the eight patients (CEE/MPA During treatment, 3272 [2735 unique for CEE/MPA; 340 for (EAmong the 3272 genes, IPA classified 225 genes as “affecting mammary tumor development”, 198 genes for CEE/MPA, and 34 for (E